GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Ifng | decreases expression | EXP | | 6480464 | CTD | bisphenol A results in decreased expression of IFNG mRNA | PMID:18569609 PMID:19267065 PMID:25181051 | Ifng | multiple interactions | EXP | | 6480464 | CTD | [Phytochemicals co-treated with bisphenol A] results in decreased expression of IFNG | PMID:20136622 | Ifng | increases expression | ISO | IFNG (Homo sapiens) | 6480464 | CTD | bisphenol A results in increased expression of IFNG mRNA | PMID:19415476 | Ifng | increases expression | ISO | Ifng (Mus musculus) | 6480464 | CTD | bisphenol A results in increased expression of IFNG mRNA; bisphenol A results in increased expression of IFNG protein | PMID:12510852 PMID:26942597 PMID:27145005 PMID:31551929 PMID:32012983 | Ifng | increases secretion | ISO | IFNG (Homo sapiens) | 6480464 | CTD | bisphenol A results in increased secretion of IFNG protein | PMID:24349194 | Ifng | increases secretion | ISO | Ifng (Mus musculus) | 6480464 | CTD | bisphenol A results in increased secretion of IFNG protein | PMID:12711627 | Ifng | multiple interactions | ISO | IFNG (Homo sapiens) | 6480464 | CTD | bisphenol A results in decreased expression of and results in decreased secretion of IFNG protein; Drugs, Chinese Herbal inhibits the reaction [bisphenol A results in increased expression of IFNG mRNA] | PMID:19415476 PMID:29192164 | Ifng | multiple interactions | ISO | Ifng (Mus musculus) | 6480464 | CTD | [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of CD36 mRNA; [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of IL1B mRNA; [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MARCO mRNA; [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA; [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of NOS2 mRNA; [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in increased expression of IL6 mRNA; [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in increased expression of TNF mRNA; [bisphenol A affects the susceptibility to Ovalbumin] which affects the expression of IFNG protein; [bisphenol A co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the expression of IFNG mRNA; bisphenol A affects the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]; bisphenol A inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD163 mRNA]; bisphenol A inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD36 mRNA]; bisphenol A inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; bisphenol A inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MARCO mRNA]; bisphenol A inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA]; bisphenol A inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; bisphenol A promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of and results in increased secretion of CCL2 protein]; bisphenol A promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of and results in increased secretion of IL6 protein]; bisphenol A promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of and results in increased secretion of TNF protein]; bisphenol A promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL2 mRNA]; bisphenol A promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 mRNA]; bisphenol A promotes the reaction [Dietary Fats results in increased expression of IFNG mRNA]; bisphenol A promotes the reaction [Ovalbumin results in increased expression of and results in increased secretion of IFNG protein]; Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of CD36 mRNA]; Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of IL1B mRNA]; Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MARCO mRNA]; Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA]; Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of NOS2 mRNA]; Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in increased expression of IL6 mRNA]; Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in increased expression of TNF mRNA]; trichostatin A affects the reaction [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]]; trichostatin A inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of CD36 mRNA]; trichostatin A inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MARCO mRNA]; trichostatin A inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in increased expression of IL6 mRNA]; trichostatin A inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in increased expression of TNF mRNA]; trichostatin A promotes the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of NOS2 mRNA] | PMID:29718165 PMID:29737898 PMID:33203037 PMID:33265944 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |